Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2021-12-30 Governance Information
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
信息披露管理制度
Governance Information Classification · 95% confidence The document is a comprehensive information disclosure management system of Guangdong Drive Biological Technology Co., Ltd. It details the principles, responsibilities, types of reports (annual, interim, quarterly, and temporary reports), procedures for disclosure, and regulatory compliance related to information disclosure. It references annual reports, interim reports, audit reports, and other regulatory requirements but does not itself contain financial statements or specific financial results. Instead, it is a governance and procedural document outlining how the company manages and discloses information to comply with securities laws and stock exchange rules. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices related to disclosure and compliance.
2021-12-30 Chinese
募集资金管理制度
Regulatory Filings Classification · 95% confidence The document is titled '广东驱动力生物科技股份有限公司募集资金管理制度' which translates to 'Guangdong Driving Force Biotechnology Co., Ltd. Fundraising Capital Management System'. It details the company's internal policies and procedures for managing and using raised funds, including storage, usage, supervision, and compliance with relevant laws and regulations. The document includes sections on approval processes, restrictions on fund usage, and reporting requirements. It is not a financial report, earnings release, or announcement of voting results. It is a regulatory compliance document outlining internal controls and governance related to capital raised by the company. The document length is about 4950 characters, and it is a substantive policy document rather than a brief announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2021-12-30 Chinese
第三届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the third meeting of the third board of directors of Guangdong Driving Force Biotechnology Co., Ltd. It details the meeting's attendance, agenda items, voting results, and references to company bylaws and governance rules. The content focuses on board decisions, amendments to company articles, and procedural matters related to governance. There is no financial data, earnings information, or audit content. The document is not a report itself but an official announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is 2371 characters, which is consistent with a meeting resolution announcement rather than a full report.
2021-12-30 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled '广东驱动力生物科技股份有限公司投资者关系管理制度' which translates to 'Investor Relations Management System of Guangdong Driving Force Biotechnology Co., Ltd.' It is a detailed policy document outlining the company's investor relations management principles, responsibilities, communication methods, and compliance with relevant laws and regulations. It does not contain financial statements, earnings data, or audit information. It is not an announcement of a report but a governance-related internal policy document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-12-30 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting System" of Guangdong Drive Biological Technology Co., Ltd., detailing the rules, procedures, powers, and governance of the shareholders' meetings. It extensively covers the conduct, rights, and responsibilities related to shareholders' meetings, including voting, proposals, and meeting records. There is no indication that this is an announcement of a meeting or voting results, nor is it a transcript or financial report. It is a governance document outlining internal rules and procedures related to shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length and detail confirm it is a full governance report, not a brief announcement or notice.
2021-12-30 Chinese
第三届监事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Guangdong Driving Force Biotechnology Co., Ltd. It details the convening and attendance of a board meeting, the approval of amendments to the Supervisory Board's rules in compliance with new listing regulations, and voting results. There is no financial data, earnings information, or detailed report content. The document is a formal announcement of board/management meeting resolutions and governance rule changes, not a full governance report or annual report. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on meeting resolutions, not a report publication or regulatory filing. Confidence is high due to clear meeting and resolution content.
2021-12-30 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.